A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
Prostate cancer is the second most diagnosed cancer among men in India, especially older men, and has a five-year survival ...
Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...
When 51-year-old Michael Lilley discovered his father John had been diagnosed with prostate cancer, he vowed to do everything ...
Veteran journalist Rajdeep Sardesai has revealed his battle with prostate cancer and shared that he underwent successful robotic surgery. His story highlights the importance of regular health checkups ...
According to reports circulating last week, the Government is set to kick into the long grass the proposal for a national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback